Evidence map›Paper›PMID 34953151›Full record

ArticleThe Laryngoscope2022

Implementing a Tailored Psychosocial Distress Screening Protocol in a Head and Neck Cancer Program.

Eden R Brauer, Stephanie Lazaro, Charlene L Williams, David A Rapkin, Amy B Madnick, Roger Dafter, Guo Cheng, Ashleigh Porter, Elliot Abemayor, Wanxing Chai-Ho and 5 more

Abstract read
In one paragraph

Article in The Laryngoscope, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Observational
4 · The record

Corrections and comments

  • Commented on by
    2022
5 · Who and what money

Authors and funding

15 authors.

Eden R BrauerDepartment of Nursing, UCLA School of Nursing, Los Angeles, California, U.S.A.ORCID 0000-0003-4895-1748
Stephanie LazaroDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Charlene L WilliamsDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
David A RapkinDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Amy B MadnickDepartment of Care Coordination and Clinical Social Work, Ronald Reagan-UCLA Medical Center, Los Angeles, California, U.S.A.
Roger DafterDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Guo ChengDepartment of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Ashleigh PorterDepartment of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Elliot AbemayorDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.ORCID 0000-0002-4680-5205
Wanxing Chai-HoDepartment of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Elizabeth MorassoDepartment of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Andrew ErmanDepartment of Audiology and Speech Pathology, Ronald Reagan-UCLA Medical Center, Los Angeles, California, U.S.A.
Dinesh ChhetriDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.
Maie St JohnDepartment of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.ORCID 0000-0001-7068-9534
Deborah J WongDepartment of Hematology Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, U.S.A.

Funding

Harnessing the EHR for the Delivery of Supportive Care in an Oncology SettingK08CA252615 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRAUER, EDEN R. · 2021 to 2025
$934k
NCI NIH HHS K08 CA252615
6 · The paper itself

Abstract

objectives/hypothesisPsychosocial distress is common among patients with head and neck cancer (HNC) and is associated with poorer quality of life and clinical outcomes. Despite these risks, distress screening is not widely implemented in HNC care. In this study, we investigated the prevalence of psychosocial distress and its related factors in routine care of patients with HNC.

methodsData from medical records between September 2017 and March 2020 were analyzed. Psychosocial distress was measured by the National Comprehensive Cancer Network's Distress Thermometer (DT), and a modified HNC-specific problem list; depression and anxiety were assessed using the Patient Health Questionnaire-4. Descriptive statistics and logistic regression were conducted to report prevalence of distress, depression and anxiety, and factors associated with clinical distress. Implementation outcomes, including rates of referrals and follow-up for distressed patients, are also reported.

resultsTwo hundred and eighty seven HNC patients completed the questionnaire (age 64.3 ± 14.9 years), with a mean distress score of 4.51 ± 3.35. Of those, 57% (n = 163) reported clinical distress (DT ≥ 4). Pain (odds ratio [OR] = 3.31, 95% CI = 1.75-6.26), fatigue (OR = 2.43, 95% CI = 1.1.7-5.05), anxiety (OR = 1.63, 95% CI = 1.30-2.05), and depression (OR = 1.51, 95% CI = 1.04-2.18) were significantly associated with clinical distress (P < .05). Of patients identified as distressed, 79% received same-day psychosocial evaluation.

conclusionsClinical distress was identified in 57% of patients who completed the questionnaire, suggesting that an ultra-brief psychosocial screening protocol can be implemented in routine ambulatory oncology care, and identifies patients whose distress might otherwise go unrecognized. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:1600-1608, 2022.

Indexed as

Head and Neck NeoplasmsNeoplasmsAgedAnxietyDepressionEarly Detection of CancerHumansMass ScreeningMiddle AgedQuality of LifeStress, PsychologicaldepressionDistress screeninghead and neck cancer

Identifiers

PMID34953151
PMCPMC9875715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.